The Effect of Dexmedetomidine of the Immune System

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Breast Cancer
Interventions
DRUG

Dexmedetomidine

After induction of general anesthesia, a loading dose of dexmedetomidine (1 mcg/kg) given in 15 min followed by an infusion of the same medication at a rate of 0.4 - 0.7 mcg/kg/hour.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

Hospira, now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER

NCT01692210 - The Effect of Dexmedetomidine of the Immune System | Biotech Hunter | Biotech Hunter